Current:Home > ScamsGameStop stock plunges after it reports quarterly financial loss -FundTrack
GameStop stock plunges after it reports quarterly financial loss
View
Date:2025-04-18 12:30:33
GameStop remains a hot property among retail investors eager to snap up the "meme stock," but its financial results continue to cool.
The video game seller on Friday reported a loss of $32.3 million on revenue of $882 million in its fiscal first quarter, with declining sales of hardware, software and collectibles. That compared with a loss of $50.5 million on revenue of $1.2 billion in the year-ago period.
"While the numbers were ugly (steep Y/Y drop in sales and a net loss, along w/neg. free cash flow of ~$115MM), they were largely in line w/the preannouncement from back on 5/17," analyst Adam Crisafulli of Vital Knowledge said in a research note.
In morning trade the company's stock fell $11.83 or 25%, to $34.73.
GameStop shares have soared in recent weeks after Keith Gill, a popular trader who touts his results online under the monikers "Roaring Kitty" and "DeepF_Value," resurfaced on social media after a long hiatus. Earlier this month, Gill posted a screenshot in a Reddit forum showing he owns roughly $116 million in GameStop shares.
The return of Roaring Kitty
In its latest jump, the company's stock price rose 47% on Thursday to close at $47.55 when Gill's Roaring Kitty YouTube channel scheduled a June 7 livestream, which would mark his first appearance on the platform in three years.
GameStop's stock also spiked in May when Gill, a financial analyst turned influencer, posted an image on X suggesting he was returning to the public eye.
Before Gill's rise to popularity, GameStop had experienced declining sales amid an industrywide pivot from game cartridges to video game streaming and digital downloads.
GameStop reported net sales of $5.2 billion for its 2023 fiscal year, down from $5.9 billion the previous year. But the company swung to a profit of $6.7 million in 2023, reversing a loss of $313.1 million in fiscal 2022.
- In:
- GameStop
Alain Sherter is a senior managing editor with CBS News. He covers business, economics, money and workplace issues for CBS MoneyWatch.
veryGood! (91514)
Related
- IRS recovers $4.7 billion in back taxes and braces for cuts with Trump and GOP in power
- 'Ghost villages' of the Himalayas foreshadow a changing India
- Transcript: Sen. Richard Blumenthal on Face the Nation, June 18, 2023
- A Young Farmer Confronts Climate Change—and a Pandemic
- Dick Vitale announces he is cancer free: 'Santa Claus came early'
- Allergic to cats? There may be hope!
- This Week in Clean Economy: Green Cards for Clean Energy Job Creators
- How to Get Rid of a Pimple Fast: 10 Holy Grail Solutions That Work in Hours
- Sarah J. Maas books explained: How to read 'ACOTAR,' 'Throne of Glass' in order.
- Transcript: Former National Security Adviser H.R. McMaster on Face the Nation, June 18, 2023
Ranking
- Finally, good retirement news! Southwest pilots' plan is a bright spot, experts say
- Iam Tongi Wins American Idol Season 21
- Washington state stockpiles thousands of abortion pills
- This Week in Clean Economy: China Is Leading the Race for Clean Energy Jobs
- Rams vs. 49ers highlights: LA wins rainy defensive struggle in key divisional game
- Rep. Cori Bush marks Juneteenth with push for reparations
- Padel, racket sport played in at least 90 countries, is gaining attention in U.S.
- Sen. Amy Klobuchar calls Texas judge's abortion pill ruling 'shocking'
Recommendation
The Best Stocking Stuffers Under $25
This Week in Clean Economy: West Coast ‘Green’ Jobs Data Shows Promise
'Oppenheimer' sex scene with Cillian Murphy sparks backlash in India: 'Attack on Hinduism'
Video: Covid-19 Drives Earth Day Anniversary Online, Inspiring Creative New Tactics For Climate Activists
House passes bill to add 66 new federal judgeships, but prospects murky after Biden veto threat
Inmate dies after escape attempt in New Mexico, authorities say
Federal appeals court preserves access to abortion drug but with tighter rules
More pollen, more allergies: Personalized exposure therapy treats symptoms